260 related articles for article (PubMed ID: 31599363)
1. Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
Shah KS; Fang JC
Curr Hypertens Rep; 2019 Oct; 21(11):86. PubMed ID: 31599363
[TBL] [Abstract][Full Text] [Related]
2. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
[TBL] [Abstract][Full Text] [Related]
3. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
Ter Maaten JM; Damman K; Verhaar MC; Paulus WJ; Duncker DJ; Cheng C; van Heerebeek L; Hillege HL; Lam CS; Navis G; Voors AA
Eur J Heart Fail; 2016 Jun; 18(6):588-98. PubMed ID: 26861140
[TBL] [Abstract][Full Text] [Related]
4. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
5. Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
Meifang W; Ying W; Wen C; Kaizu X; Meiyan S; Liming L
Heart Fail Rev; 2024 Mar; 29(2):305-320. PubMed ID: 37561223
[TBL] [Abstract][Full Text] [Related]
6. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
[TBL] [Abstract][Full Text] [Related]
7. Renal Dysfunction and Heart Failure with Preserved Ejection Fraction.
Ananthram MG; Gottlieb SS
Heart Fail Clin; 2021 Jul; 17(3):357-367. PubMed ID: 34051968
[TBL] [Abstract][Full Text] [Related]
8. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
[TBL] [Abstract][Full Text] [Related]
9. Heart failure with preserved ejection fraction: emerging drug strategies.
Zouein FA; de Castro Brás LE; da Costa DV; Lindsey ML; Kurdi M; Booz GW
J Cardiovasc Pharmacol; 2013 Jul; 62(1):13-21. PubMed ID: 23714774
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on systemic hypertension in heart failure with preserved ejection fraction.
Oktay AA; Shah SJ
Curr Cardiol Rep; 2014 Dec; 16(12):545. PubMed ID: 25326729
[TBL] [Abstract][Full Text] [Related]
11. Interrelation between heart failure with preserved ejection fraction and renal impairment.
Joslin JR; Lioudaki E; Androulakis E
Rev Cardiovasc Med; 2022 Feb; 23(2):69. PubMed ID: 35229560
[TBL] [Abstract][Full Text] [Related]
12. Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.
Agrawal A; Naranjo M; Kanjanahattakij N; Rangaswami J; Gupta S
Heart Fail Rev; 2019 Jul; 24(4):421-437. PubMed ID: 31127482
[TBL] [Abstract][Full Text] [Related]
13. Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
Tannenbaum S; Sayer GT
Curr Opin Cardiol; 2015 May; 30(3):250-8. PubMed ID: 25807227
[TBL] [Abstract][Full Text] [Related]
14. Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction.
Kim MN; Park SM
Heart Fail Clin; 2021 Jul; 17(3):463-482. PubMed ID: 34051977
[TBL] [Abstract][Full Text] [Related]
15. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ
Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439
[TBL] [Abstract][Full Text] [Related]
16. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
Unger ED; Dubin RF; Deo R; Daruwalla V; Friedman JL; Medina C; Beussink L; Freed BH; Shah SJ
Eur J Heart Fail; 2016 Jan; 18(1):103-12. PubMed ID: 26635076
[TBL] [Abstract][Full Text] [Related]
17. Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
Salah EM; Bastacky SI; Jackson EK; Tofovic SP
J Cardiovasc Pharmacol; 2018 Apr; 71(4):205-214. PubMed ID: 29620605
[TBL] [Abstract][Full Text] [Related]
18. Heart Failure with Preserved Ejection Fraction.
Gladden JD; Chaanine AH; Redfield MM
Annu Rev Med; 2018 Jan; 69():65-79. PubMed ID: 29414252
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Heart Failure with Preserved Ejection Fraction.
Ilieșiu AM; Hodorogea AS
Adv Exp Med Biol; 2018; 1067():67-87. PubMed ID: 29498023
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).
Sala V; Margaria JP; Murabito A; Morello F; Ghigo A; Hirsch E
Curr Heart Fail Rep; 2017 Jun; 14(3):187-196. PubMed ID: 28451983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
